Therapy With Abraxane and 5-Fluorouracil, Epirubicin, Cyclophosphamide (FEC) for Patients With Breast Cancer
Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn how breast cancer tumors respond to a drug called
Abraxane followed by a combination of 3 chemotherapy drugs commonly used for breast cancer.